يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Ken Uchibori"', وقت الاستعلام: 0.73s تنقيح النتائج
  1. 1
    Soluble interleukin-2 receptor as a predictive biomarker for poor efficacy of combination treatment with anti-PD-1/PD-L1 antibodies and chemotherapy in non-small cell lung cancer patients

    المؤلفون: Takehiro Tozuka, Noriko Yanagitani, Hiroshi Yoshida, Ryo Manabe, Shinsuke Ogusu, Ryosuke Tsugitomi, Hiroaki Sakamoto, Yoshiaki Amino, Ryo Ariyasu, Ken Uchibori, Satoru Kitazono, Masahiro Seike, Akihiko Gemma, Makoto Nishio

    المصدر: Investigational New Drugs.

    مصطلحات موضوعية: Pharmacology, Oncology, Pharmacology (medical)

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::97a654b36bc107428b3b561f7291cc5dTest
    https://doi.org/10.1007/s10637-023-01358-3Test


    أضف إلى المفضلة
  2. 2
    Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors

    المؤلفون: Akihiko Gemma, Ken Uchibori, Takeshi Horai, Takehiro Tozuka, Masahiro Seike, Atsushi Horiike, Noriko Yanagitani, Hiroshi Yoshida, Yoshiaki Amino, Makoto Nishio, Takahiro Yoshizawa, Hiroaki Sakamoto, Shinya Uematsu, Satoru Kitazono, Tsukasa Hasegawa

    المصدر: BMC Cancer
    BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)

    مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, Gastroenterology, Immune checkpoint inhibitors, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Non-small cell lung cancer, Surgical oncology, Carcinoma, Non-Small-Cell Lung, Internal medicine, Genetics, medicine, Humans, Lung cancer, Aged, Retrospective Studies, Aged, 80 and over, Proportional hazards model, business.industry, Hazard ratio, Cancer, Retrospective cohort study, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prognosis, medicine.disease, Survival Analysis, Confidence interval, Nivolumab, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, Dissociated responses, Tomography, X-Ray Computed, business, Progressive disease, Research Article

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c8ac12f5bf9eb83b622738fcd3ddd93Test
    https://doi.org/10.1186/s12885-020-6704-zTest


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث